7.44
前日終値:
$7.47
開ける:
$7.49
24時間の取引高:
280.20K
Relative Volume:
0.84
時価総額:
$470.01M
収益:
$198.53M
当期純損益:
$-63.68M
株価収益率:
-7.2784
EPS:
-1.0222
ネットキャッシュフロー:
$-41.50M
1週間 パフォーマンス:
+3.48%
1か月 パフォーマンス:
+30.53%
6か月 パフォーマンス:
-23.30%
1年 パフォーマンス:
+18.47%
Treace Medical Concepts Inc Stock (TMCI) Company Profile
名前
Treace Medical Concepts Inc
セクター
電話
(904) 373-5940
住所
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TMCI
Treace Medical Concepts Inc
|
7.44 | 444.74M | 198.53M | -63.68M | -41.50M | -1.0222 |
![]()
ABT
Abbott Laboratories
|
131.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.39 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
394.33 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.18 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
81.27 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-04 | アップグレード | BTIG Research | Neutral → Buy |
2024-12-31 | 開始されました | Lake Street | Buy |
2024-12-17 | 再開されました | JP Morgan | Neutral |
2024-05-16 | ダウングレード | UBS | Buy → Neutral |
2024-05-08 | ダウングレード | BTIG Research | Buy → Neutral |
2024-05-08 | ダウングレード | JP Morgan | Overweight → Neutral |
2024-05-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-05-08 | ダウングレード | Stifel | Buy → Hold |
2024-05-08 | ダウングレード | Truist | Buy → Hold |
2023-09-29 | 開始されました | UBS | Buy |
2023-05-01 | 開始されました | Truist | Buy |
2023-04-11 | 開始されました | Stephens | Equal-Weight |
2022-05-12 | 開始されました | BTIG Research | Buy |
2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2021-05-18 | 開始されました | JP Morgan | Overweight |
2021-05-18 | 開始されました | Morgan Stanley | Equal-Weight |
2021-05-18 | 開始されました | SVB Leerink | Outperform |
2021-05-18 | 開始されました | Stifel | Buy |
すべてを表示
Treace Medical Concepts Inc (TMCI) 最新ニュース
Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Shares Leap 27% Yet They're Still Not Telling The Full Story - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Raises Position in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts Inc. Forms Double Bottom Pattern — Eyes on BreakoutProduct Launch & Fast Entry Momentum Alerts - Newser
Visual trend scoring systems applied to Treace Medical Concepts Inc.Market Performance Recap & Real-Time Volume Trigger Notifications - Newser
Key resistance and support levels for Treace Medical Concepts Inc.July 2025 Summary & Long-Term Growth Portfolio Plans - Newser
Is Treace Medical Concepts Inc. trending in predictive chart modelsWeekly Investment Recap & Community Verified Trade Alerts - Newser
Treace Medical Concepts Inc. Added to High Probability Setup ListJuly 2025 Macro Moves & Real-Time Market Trend Scan - beatles.ru
What earnings revisions data tells us about Treace Medical Concepts Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
Risk vs reward if holding onto Treace Medical Concepts Inc.Quarterly Investment Review & Free Reliable Trade Execution Plans - Newser
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of DoubleVerify - GlobeNewswire
Treace Medical Concepts Inc. stock prediction for this weekTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Does Treace Medical Concepts Inc. fit your quant trading modelQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
Using portfolio simulators with Treace Medical Concepts Inc. includedJuly 2025 Movers & Safe Capital Investment Plans - Newser
How to interpret RSI for Treace Medical Concepts Inc. stockJuly 2025 Market Mood & Safe Entry Trade Reports - Newser
How high can Treace Medical Concepts Inc. stock go2025 Macro Impact & Low Risk Entry Point Tips - Newser
Published on: 2025-08-18 22:09:59 - Newser
Evaluating Treace Medical Concepts Inc. with trendline analysisPortfolio Performance Summary & Capital Protection Trading Alerts - Newser
Competitive Positioning of Treace Medical Concepts Inc.: Is It Leading or LaggingJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Analyzing Treace Medical Concepts Inc. with risk reward ratio chartsInflation Watch & Fast Entry Momentum Alerts - Newser
Key metrics from Treace Medical Concepts Inc.’s quarterly dataMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Treace Medical Concepts: Positive Q2 Earnings Call Highlights - MSN
Historical volatility pattern of Treace Medical Concepts Inc. visualizedChart Signals & Low Volatility Stock Suggestions - Newser
Is Treace Medical Concepts Inc. stock ready for a breakoutWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
Is Treace Medical Concepts Inc. forming a reversal patternJuly 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Backtesting results for Treace Medical Concepts Inc. trading strategiesEarnings Recap Summary & Capital Efficiency Focused Ideas - Newser
What recovery options are there for Treace Medical Concepts Inc.July 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Arcadia Wealth Management Inc. Takes Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
UBS Group Reaffirms Neutral Rating for Treace Medical Concepts (NASDAQ:TMCI) - MarketBeat
Stifel Nicolaus Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Investigation announced for Investors who hold shares of Treace - openPR.com
SEC Filings Archive 2025-08-12Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions - MSN
What makes Treace Medical Concepts Inc. stock price move sharplyShort Term Risk Controlled Alerts - beatles.ru
Analysts Have Been Trimming Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target After Its Latest Report - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during market volatilityShort Term Gain Strategy with AI Logic - Newser
Insider Stock Buying Reaches US$1.80m On Treace Medical Concepts - 富途牛牛
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st
Treace Medical Concepts Inc (TMCI) 財務データ
収益
当期純利益
現金流量
EPS
Treace Medical Concepts Inc (TMCI) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Option Exercise |
1.05 |
50,000 |
52,500 |
414,081 |
Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Sale |
7.97 |
50,000 |
398,460 |
364,081 |
大文字化:
|
ボリューム (24 時間):